Five evolving challenges facing OPOs and how technology can help unlock more viable organs

Five Evolving Challenges Facing OPOs And How Technology 
Can Help Unlock More Viable Organs

By Tara Psencik, CEO, BSN, RN

Organ Procurement Organizations (OPOs) sit at the center of one of healthcare’s most complex and time-sensitive ecosystems. They are tasked with maximizing organ recovery, ensuring donor stability, coordinating across hospitals, and ultimately increasing the number of lives saved through transplantation.

Despite advancements in policy, technology, and clinical practice, OPOs continue to face persistent, and in many cases, growing challenges that limit organ utilization and introduce variability in outcomes.

 

Five Core Challenges OPOs Face Today

1. A Persistent Gap Between Organ Supply and Demand

The most fundamental challenge remains unchanged: there are not enough viable organs. More than 100,000 patients in the United States are currently waiting for a transplant, with thousands dying each year while waiting.¹

Importantly, many potential donor organs are never utilized—not due to lack of availability, but because they are deemed non-viable at procurement. This highlights a critical opportunity: improving donor management to increase utilization.

 

2. Physiologic Instability After Brain Death

Brain death triggers profound physiologic changes that threaten organ viability, including hemodynamic instability, systemic inflammation, and impaired oxygenation.²

The lungs are particularly vulnerable:

  • Atelectasis due to loss of respiratory drive 
  • Ventilation-perfusion (V/Q) mismatch 
  • Ventilator-associated lung injury

These factors often result in lungs—and sometimes additional organs—being ruled out despite otherwise suitable donor profiles.

 

3. Suboptimal Ventilation Strategies

Even when best practices are known, they are not consistently applied. Studies show that only about 25% of donors receive lung-protective ventilation, despite strong evidence linking it to increased lung procurement rates.³

This gap underscores a broader issue: inconsistency in execution across care settings.

 

4. Variability Across Hospitals and Care Teams

OPOs operate across a wide range of hospital environments with varying:

  • Staffing levels 
  • Clinical expertise 
  • Protocol adherence 

This variability leads to uneven donor management and inconsistent outcomes. Regulatory changes have introduced standardized performance metrics, but bedside variability remains a major barrier.⁴

 

5. Workflow Burden and Staffing Constraints

Critical care teams are frequently resource-constrained. Interventions like prone positioning,while clinically beneficial, have challenges:

  • Labor-intensive 
  • Physically demanding 
  • Time-sensitive 
  • Inconsistently implemented 

As a result, high-impact therapies may be underutilized simply due to operational challenges.

 

Why Ventilation and Perfusion Are Central to Organ Viability

Adequate ventilation and perfusion are foundational to maintaining organ function in donors.

Poor oxygenation has cascading effects:

  • Lungs: Increased atelectasis and reduced transplant eligibility 
  • Heart: Impaired myocardial performance 
  • Liver and kidneys: Increased susceptibility to ischemic injury 

In essence, suboptimal lung management compromises multi-organ viability.

 

The Role of Prone Positioning in Donor Optimization

Prone positioning is a well-established intervention that improves pulmonary physiology. In the context of donor management, it represents one of the most impactful yet underutilized tools available to improve organ viability.

 

Physiologic Benefits

Proning has been shown to:

  • Improve ventilation-perfusion matching 
  • Increase oxygenation 
  • Reduce atelectasis 
  • Promote more uniform lung recruitment⁵ 

These effects directly address the mechanisms that often render donor lungs unusable.

 

Evidence Linking Proning to Increased Lung Utilization

Beyond physiologic improvements, clinical data demonstrates that prone positioning can directly increase transplantable organ yield.

Macklin et al. evaluated prone positioning in brain-dead donors and found that:

  • Proning rapidly reversed atelectasis and hypoxemia 
  • PaO₂/FiO₂ ratios improved significantly, often shifting donors into transplant-eligible ranges 
  • Most importantly, these improvements translated into a higher number of lungs being transplanted 

This is a critical distinction: prone positioning is not just improving numbers on a monitor, it is changing clinical decision-making and increasing organ utilization.

Additional reports further reinforce this finding, showing that:

  • Lungs initially deemed non-viable can become transplantable after prone positioning 
  • Improvements in oxygenation can occur within hours, making this a time-sensitive and high-impact intervention⁷ 

For OPOs, this highlights a key opportunity: lung viability is often dynamic and can be actively improved with the right intervention at the right time.

 

Impact Beyond the Lungs

The benefits of prone positioning extend beyond pulmonary outcomes.

Improved oxygenation:

  • Enhances systemic oxygen delivery 
  • Supports cardiac performance 
  • Preserves liver and kidney function 

Importantly, prone positioning has been shown to:

  • Maintain hemodynamic stability
  • Avoid negative effects on other transplantable organs⁵ 

This reinforces a central principle in donor management: optimizing the lungs supports the viability of all organs.

 

The Implementation Gap

Despite strong evidence, prone positioning remains inconsistently utilized due to operational barriers.

Manual proning:

  • Requires multiple caregivers 
  • Carries risk of staff injury 
  • Is difficult to standardize 
  • Varies widely across institution 

As a result, there is a clear gap between what is clinically effective and what is consistently implemented.

How the Pronova-O2® Automated Prone Therapy System Addresses These Challenges

The Pronova-O2® is designed to close this gap, bringing consistency, scalability, and efficiency to donor management.

 

1. Improving Lung Viability Through Consistent Pronation

By enabling safe, repeatable prone positioning, Pronova-O2® helps:

  • Improve oxygenation and P/F ratios
  • Reverse atelectasis
  • Increase the likelihood of lung utilization

This directly addresses one of the most common causes of organ discard.

 

2. Enhancing Multi-Organ Viability

Improved ventilation leads to improved systemic oxygen delivery.

With Pronova-O2®:

  • Cardiac function is better supported
  • Liver and kidney perfusion is preserved
  • Risk of hypoxic injury is reduced

Optimizing lung function helps preserve the entire donor.

 

3. Standardizing Care Across Hospitals

One of the most significant advantages of automation is consistency.

Pronova-O2® enables:

  • Protocol-driven prone therapy
  • Reduced dependence on individual clinician experience
  • Replication of best practices across hospitals

This reduces variability which is one of the most persistent challenges facing OPOs.

 

4. Reducing Workflow Burden

Automation removes many of the barriers associated with manual proning:

  • Fewer staff required
  • Reduced risk of caregiver injury
  • Faster and more efficient repositioning

This allows clinical teams to deliver high-quality care without increasing workload.

 

5. Scaling Best Practices Across OPO Networks

Pronova-O2® allows OPOs to move from variable, site-dependent care to standardized donor optimization across their entire service area.

This enables:

  • More consistent outcomes
  • Greater organ utilization
  • Improved alignment with regulatory expectations

 

The Future of Donor Management

The future of transplantation depends not only on increasing donor numbers, but on maximizing the viability of every donor.

We already know that:

  • Ventilation strategies directly impact transplant outcomes
  • Prone positioning improves oxygenation and lung utilization
  • Standardization reduces variability and improves consistency
  • The remaining challenge is implementation.

Automated prone therapy offers a scalable solution—bridging the gap between evidence and practice and helping ensure that more donors reach their full potential.

 

Final Thought

OPOs are under increasing pressure to deliver better outcomes with greater consistency.

The path forward is clear: reliable, evidence-based donor management delivered at scale.

Automated prone therapy represents a meaningful step in that direction—helping convert more potential donors into lifesaving transplants.

References (AMA Style)

  1. Organ Procurement and Transplantation Network. National Data Reports. Accessed April 1, 2026. 
  2. Malinoski DJ, Daly MC, Patel MS, et al. Achieving donor management goals before deceased donor procurement is associated with more organs transplanted per donor. Am J Transplant. 2011;11(11):2268-2276. 
  3. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. Am J Respir Crit Care Med. 2010;182(2):167-173. 
  4. National Bureau of Economic Research. Consequences of organ procurement reform. Published 2025. 
  5. Turner Medical. Prone positioning and organ procurement. Accessed April 1, 2026. 
  6. Macklin PS, et al. Ventilation in the prone position improves oxygenation and results in more lungs being transplanted. J Heart Lung Transplant. 2020. 
  7. Son E, Jang J, Cho WH, et al. Successful lung transplantation after prone positioning in an ineligible donor: a case report. Gen Thorac Cardiovasc Surg. 2021.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment